10078083

Source:http://linkedlifedata.com/resource/pubmed/id/10078083

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004238, umls-concept:C0004239, umls-concept:C0037707, umls-concept:C0082966, umls-concept:C0450442, umls-concept:C0456387, umls-concept:C0680218, umls-concept:C1257890, umls-concept:C1707454, umls-concept:C2603343
pubmed:issue	6
pubmed:dateCreated	1999-3-18
pubmed:abstractText	To compare the efficacy and safety of a single dose of ibutilide, a new class III antiarrhythmic drug, with that of DL-sotalol in terminating chronic atrial fibrillation or flutter in haemodynamically stable patients.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-1320693, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-1376795, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-1697384, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-1734660, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-2123909, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-2242545, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-2294683, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-3103410, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-3137061, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-3338122, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-3548521, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-7505355, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-7586381, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-7596120, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-7671380, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-7694244, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-7752661, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-7882490, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-7900626, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-8202100, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-8752805, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-8840835, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-8840852, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-8853021, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-9014993, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-9107155, http://linkedlifedata.com/resource/pubmed/commentcorrection/10078083-9416896
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9602087
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Arrhythmia Agents, http://linkedlifedata.com/resource/pubmed/chemical/Sotalol, http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides, http://linkedlifedata.com/resource/pubmed/chemical/ibutilide
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1355-6037
pubmed:author	pubmed-author:GolitsynS RSR, pubmed-author:HarryJ DJD, pubmed-author:PerryK TKT, pubmed-author:RudR CRC, pubmed-author:RudaM YMY, pubmed-author:StanglKK, pubmed-author:SteinbeckGG, pubmed-author:TouboulPP, pubmed-author:Van WijkL VLV, pubmed-author:WellensH JHJ
pubmed:issnType	Print
pubmed:volume	79
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	568-75
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:10078083-Adult, pubmed-meshheading:10078083-Aged, pubmed-meshheading:10078083-Aged, 80 and over, pubmed-meshheading:10078083-Analysis of Variance, pubmed-meshheading:10078083-Anti-Arrhythmia Agents, pubmed-meshheading:10078083-Arrhythmias, Cardiac, pubmed-meshheading:10078083-Atrial Fibrillation, pubmed-meshheading:10078083-Atrial Flutter, pubmed-meshheading:10078083-Double-Blind Method, pubmed-meshheading:10078083-Drug Administration Schedule, pubmed-meshheading:10078083-Female, pubmed-meshheading:10078083-Humans, pubmed-meshheading:10078083-Infusions, Intravenous, pubmed-meshheading:10078083-Male, pubmed-meshheading:10078083-Middle Aged, pubmed-meshheading:10078083-Prospective Studies, pubmed-meshheading:10078083-Sotalol, pubmed-meshheading:10078083-Sulfonamides, pubmed-meshheading:10078083-Time Factors
pubmed:year	1998
pubmed:articleTitle	Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.
pubmed:affiliation	Department of Cardiology, University Hospital Maastricht, Netherlands.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study